Findings suggest that routine urine drug screening in the ICCU could improve risk stratification, help personalize drug ...

A retrospective cohort study found that beta-blocker use is associated with a decreased risk for incident HF in certain SAID populations.

US health officials are proposing a new way to develop and approve custom-made treatments for people with rare and ...

HealthDay News — COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia (PE), ...

GLP1-RA use may be linked to improved overall survival, but not improved disease-free survival, in breast cancer survivors, ...

For individuals with high BP, baduanjin, a traditional Chinese mind-body practice, can lower SBP, with effects sustained for ...

Glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy was associated with reduced Parkinson disease (PD) risk.

Wildfire smoke exposure during pregnancy may increase the risk for autism spectrum disorder (ASD), according to a new study.

FDA approves swallowable Allurion Gastric Balloon for weight loss in adults with obesity who failed prior lifestyle programs.

Elevated peak donor troponin levels are associated with an increased risk for 1-year graft loss in pediatric heart transplant ...

The US Food and Drug Administration (FDA) is relaxing a long-standing drug approval requirement for common diseases.

Community-based multilevel interventions show no overall significant effect on body mass index (BMI) z‐scores among rural Hispanic children.